The UK government will allow for a limited period of time certain innovative medicines to be used by the National Health Service without them having been evaluated for cost effectiveness by the country’s health technology assessment body, the National Institute for Health and Clinical Excellence 1...
Please login to read the full article.Welcome:
IBI01 - Circulation
scr
RAJ Pharma
Some drugs in UK to skip cost-effectiveness appraisal
31 July 2009
Vibha Sharma
RELATED CONTENT
NEWS
RAJ Pharma News
Other Informa News
ANALYSIS
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
RAJ Pharma Features
Other Informa Features
COUNTRY PROFILES
RAJ Pharma Country Profiles
Other Informa Country Profiles
COMMENT
RAJ Pharma Comment
Other Informa Comments
EVENTS
October 4th, 2010
London, UK
October 19th, 2010
Barcelona, Spain
October 20th, 2010
Barcelona, Spain